Cargando…
Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers
BACKGROUND: Data are scarce about tumor mutational burden (TMB) as a biomarker in never smokers with non–small cell lung cancer (NSCLC). METHODS: TMB was assessed by whole-genome sequencing (WGS) and compared with in silico reduced whole-exome sequencing (WES) and targeted commercial next-generation...
Autores principales: | Ruel, Louis-Jacques, Li, Zhonglin, Gaudreault, Nathalie, Henry, Cyndi, Saavedra Armero, Victoria, Boudreau, Dominique K., Zhang, Tongwu, Landi, Maria Teresa, Labbé, Catherine, Couture, Christian, Desmeules, Patrice, Joubert, Philippe, Bossé, Yohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720425/ https://www.ncbi.nlm.nih.gov/pubmed/36126278 http://dx.doi.org/10.1158/1055-9965.EPI-22-0630 |
Ejemplares similares
-
Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC
por: Desmeules, Patrice, et al.
Publicado: (2022) -
Tumor-based gene expression biomarkers to predict survival following curative intent resection for stage I lung adenocarcinoma
por: Clemenceau, Alisson, et al.
Publicado: (2018) -
Retrospective Assessment of Complementary Liquid Biopsy on Tissue Single-Gene Testing for Tumor Genotyping in Advanced NSCLC
por: Desmeules, Patrice, et al.
Publicado: (2023) -
A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination
por: Bossé, Yohan, et al.
Publicado: (2023) -
Phenome-wide analyses establish a specific association between aortic valve PALMD expression and calcific aortic valve stenosis
por: Li, Zhonglin, et al.
Publicado: (2020)